BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 3596736)

  • 1. Immunochemical studies of the uroporphyrinogen decarboxylase defect caused by hexachlorobenzene.
    Elder GH; Urquhart AJ
    IARC Sci Publ; 1986; (77):441-8. PubMed ID: 3596736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accumulation of uroporphyrin does not provoke further inhibition of liver uroporphyrinogen decarboxylase activity in hexachlorobenzene-induced porphyria.
    Adjarov DG; Elder GH
    IARC Sci Publ; 1986; (77):467-9. PubMed ID: 3596742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Porphyrinogenic effect of hexachlorobenzene and 2,3,7,8-tetrachlorodibenzo-para-dioxin: is an inhibitor involved in uroporphyrinogen decarboxylase inactivation?
    Cantoni L; Graziani A; Rizzardini M; Saletti MC
    IARC Sci Publ; 1986; (77):449-56. PubMed ID: 3596737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative abilities on a molar basis of hexafluoro-, hexachloro- and hexabromobenzenes to decrease liver uroporphyrinogen decarboxylase activity and cause porphyria in female rats.
    Smith AG; Francis JE
    Res Commun Chem Pathol Pharmacol; 1980 May; 28(2):377-84. PubMed ID: 7394329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the mechanism of uroporphyrinogen decarboxylase inhibition in hexachlorobenzene-induced porphyria in the female rat.
    Mylchreest E; Charbonneau M
    Toxicol Appl Pharmacol; 1997 Jul; 145(1):23-33. PubMed ID: 9221820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic studies of the inhibition of hepatic uroporphyrinogen decarboxylase in C57BL/10 mice by iron-hexachlorobenzene synergism.
    Smith AG; Francis JE; Kay SJ; Greig JB; Stewart FP
    Biochem J; 1986 Sep; 238(3):871-8. PubMed ID: 3800966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The involvement of iron and lipid peroxidation in the pathogenesis of HCB induced porphyria.
    Alleman MA; Koster JF; Wilson JH; Edixhoven-Bosdijk A; Slee RG; Kroos MJ; von Eijk HG
    Biochem Pharmacol; 1985 Jan; 34(2):161-6. PubMed ID: 3966921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continued depression of hepatic uroporphyrinogen decarboxylase activity caused by hexachlorobenzene or 2,3,7,8-tetrachlorodibenzo-p-dioxin despite regeneration after partial hepatectomy.
    Smith AG; Francis JE; Greig JB
    Biochem Pharmacol; 1985 May; 34(10):1817-20. PubMed ID: 4004897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of iron in the hexachlorobenzene induced porphyria. I. Studies on different types of iron and its relation with porphyrinogen carboxy-lyase decrease.
    Wainstok de Calmanovici R; Ríos de Molina MC; San Martín de Viale LC
    Acta Physiol Pharmacol Latinoam; 1985; 35(4):481-91. PubMed ID: 2940809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rat-liver porphyrinogen carboxy-lyase inhibition as a function of the degree of hexachlorobenzene-induced porphyria.
    Billi SC; Wainstok de Calmanovici R; San Martín de Viale LC
    IARC Sci Publ; 1986; (77):487-91. PubMed ID: 3596746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic, iron status and sex factors of porphyria induced by hexachlorobenzene.
    Smith AG; Stewart FP; Francis JE
    IARC Sci Publ; 1986; (77):433-9. PubMed ID: 3596735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoreactive uroporphyrinogen decarboxylase is unchanged in porphyria caused by TCDD and hexachlorobenzene.
    Elder GH; Sheppard DM
    Biochem Biophys Res Commun; 1982 Nov; 109(1):113-20. PubMed ID: 7159416
    [No Abstract]   [Full Text] [Related]  

  • 13. Synergism of iron and hexachlorobenzene inhibits hepatic uroporphyrinogen decarboxylase in inbred mice.
    Smith AG; Francis JE
    Biochem J; 1983 Sep; 214(3):909-13. PubMed ID: 6626162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver porphyrinogen carboxylase in hexachlorobenzene porphyric rats. Studies with intermediate porphyrinogens of series III and with uroporphyrinogen I.
    Ríos de Molina MC; Wainstok de Calmanovici R; San Martín de Viale LC
    Int J Biochem; 1987; 19(4):365-72. PubMed ID: 3595984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the role of iron in the alterations observed in hexachlorobenzene-induced porphyria.
    Wainstok de Calmanovici R; Ríos de Molina Mdel C; Vila MC; San Martín de Viale LC
    IARC Sci Publ; 1986; (77):497-503. PubMed ID: 3596748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemically-induced formation of an inhibitor of hepatic uroporphyrinogen decarboxylase in inbred mice with iron overload.
    Smith AG; Francis JE
    Biochem J; 1987 Aug; 246(1):221-6. PubMed ID: 3675556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal kinetic behavior of uroporphyrinogen decarboxylase obtained from rats with hexachlorobenzene-induced porphyria.
    Chaufan G; Corvi MM; San Martín de Viale LC; Cárdenas ML; Ríos de Molina Mdel C
    J Biochem Mol Toxicol; 2005; 19(1):19-24. PubMed ID: 15736160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of an iron chelator on the onset of hexachlorobenzene-induced porphyria in rats.
    Wainstok de Calmanovici R; Billi SC; Aldonatti CA; San Martín de Viale LC
    IARC Sci Publ; 1986; (77):507-11. PubMed ID: 3596749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental hepatic porphyria caused by hexachlorobenzene: mechanism of the metabolic block.
    De Matteis F
    IARC Sci Publ; 1986; (77):427-31. PubMed ID: 3596734
    [No Abstract]   [Full Text] [Related]  

  • 20. Hexachlorobenzene porphyria in rats as a model for human chronic hepatic porphyrias.
    Doss M; Schermuly E; Koss G
    Ann Clin Res; 1976; 8 Suppl 17():171-81. PubMed ID: 1008488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.